MX9705198A - Metodos y formulaciones a base de colagena para el tratamiento de enfermedades mediadas por el sistema inmune. - Google Patents

Metodos y formulaciones a base de colagena para el tratamiento de enfermedades mediadas por el sistema inmune.

Info

Publication number
MX9705198A
MX9705198A MX9705198A MX9705198A MX9705198A MX 9705198 A MX9705198 A MX 9705198A MX 9705198 A MX9705198 A MX 9705198A MX 9705198 A MX9705198 A MX 9705198A MX 9705198 A MX9705198 A MX 9705198A
Authority
MX
Mexico
Prior art keywords
collagen
immune system
mediated diseases
subject
methods
Prior art date
Application number
MX9705198A
Other languages
English (en)
Spanish (es)
Inventor
Thomas B Neff
George R Martin
Karl A Piez
Taina Z Pihlajaniemi
Karl I Kivirikko
Original Assignee
Fibrogen Inc
Academy Of Finland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fibrogen Inc, Academy Of Finland filed Critical Fibrogen Inc
Publication of MX9705198A publication Critical patent/MX9705198A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX9705198A 1995-01-10 1996-01-11 Metodos y formulaciones a base de colagena para el tratamiento de enfermedades mediadas por el sistema inmune. MX9705198A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37038895A 1995-01-10 1995-01-10
PCT/US1996/000533 WO1996021458A1 (en) 1995-01-10 1996-01-11 Collagen-based methods and formulations for the treatment of immune system-mediated diseases

Publications (1)

Publication Number Publication Date
MX9705198A true MX9705198A (es) 1997-12-31

Family

ID=23459429

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9705198A MX9705198A (es) 1995-01-10 1996-01-11 Metodos y formulaciones a base de colagena para el tratamiento de enfermedades mediadas por el sistema inmune.

Country Status (10)

Country Link
EP (1) EP0805686A1 (fi)
JP (1) JPH10512554A (fi)
AU (1) AU4657096A (fi)
BR (1) BR9606753A (fi)
CA (1) CA2210088A1 (fi)
FI (1) FI972929A (fi)
HU (1) HUP9800829A3 (fi)
MX (1) MX9705198A (fi)
NO (1) NO973193L (fi)
WO (1) WO1996021458A1 (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856446A (en) * 1995-07-07 1999-01-05 Autoimmune Inc. Method of treating rheumatoid arthritis with low dose type II collagen
US6391303B1 (en) * 1996-11-18 2002-05-21 Emisphere Technologies, Inc. Methods and compositions for inducing oral tolerance in mammals
US7097845B2 (en) 1997-04-23 2006-08-29 Jacob Sten Petersen Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
DE19804210A1 (de) * 1998-02-03 1999-08-12 Biosyn Arzneimittel Gmbh Rekombinante Mistellektine
MXPA01001510A (es) * 1998-08-10 2003-08-20 Fibrogen Inc Composiciones hemostaticas de colageno tipo i y tipo iii para usarse como sellador vascular y vendaje para heridas.
KR102577697B1 (ko) * 2019-11-13 2023-09-14 주식회사 나이벡 염증 및 상처 치료용 펩타이드
EP4072608A1 (en) * 2019-12-12 2022-10-19 Instituto de Engenharia Biomédica (INEB) Fetal decellularized nucleus pulposus material and methods for obtaining pharmaceutic compositions to be used in the treatment of intervertebral disc degeneration and back pain
DE102021214899A1 (de) * 2021-12-22 2023-06-22 Gelita Ag Typ I-Kollagenpeptid zur therapeutischen Verwendung
JP7357189B1 (ja) * 2022-07-14 2023-10-06 株式会社リナイス 魚類軟骨由来のコラーゲン含有組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399347A (en) * 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen

Also Published As

Publication number Publication date
CA2210088A1 (en) 1996-07-18
HUP9800829A3 (en) 1999-09-28
BR9606753A (pt) 1998-01-06
EP0805686A1 (en) 1997-11-12
FI972929A0 (fi) 1997-07-10
AU4657096A (en) 1996-07-31
HUP9800829A2 (hu) 1998-07-28
WO1996021458A1 (en) 1996-07-18
FI972929A (fi) 1997-09-10
JPH10512554A (ja) 1998-12-02
NO973193L (no) 1997-09-09
NO973193D0 (no) 1997-07-09

Similar Documents

Publication Publication Date Title
IL99754A0 (en) Pharmaceutical composition for treatment of autoimmune diseases containing an autoantigen or a fragment or analogue thereof
DK0627933T3 (da) Bystander-suppression af autoimmune sygdomme
ATE130762T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
PT831882E (pt) Composicoes de segmentos de fibra de colagenio reconstituido e metodos de preparacao das mesmas
AU2338497A (en) Conjugated linoleic acid to maintain or enhance bone mineral content
ATE82127T1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
MX9705198A (es) Metodos y formulaciones a base de colagena para el tratamiento de enfermedades mediadas por el sistema inmune.
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
ATE254924T1 (de) Stör-notokord zur verminderung der symptome / behandlung von arthritis
BG105275A (en) Tan-1057 derivatives
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
EP0347899A3 (en) Pharmaceutical compositions on egg shell basis and their preparation and use
DE69816808D1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
ATE194076T1 (de) Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen
ATE318612T1 (de) Methoden und zusammensetzungen zur behandlung der hyperlipidämie
MX9800686A (es) Nueva proteina hmw humana mp52s.